
SKBR3 - Wikipedia
SkBr3 (also known as SK-BR-3) is a human breast cancer cell line isolated by the Memorial Sloan–Kettering Cancer Center in 1970 that is used in therapeutic research, especially in …
SK-BR-3 [SKBR3] - HTB-30 - ATCC
SK-BR-3 [SKBR3] cells were isolated in 1970 from pleural effusion cells of a 43-year-old, White, female adenocarcinoma patient with blood type A+ who had been treated with radiation, …
SKBR3: Notable Breakthroughs in Breast Cancer Cell Science
Mar 18, 2025 · SKBR3 cells have played a significant role in breast cancer research, particularly in understanding HER2-positive tumors. As a widely studied human breast cancer cell line, …
The SKBR3 cell-membrane proteome reveals telltales of aberrant …
The metastatic SKBR3 cell-membrane proteome revealed a broad and rich map of receptors, immune response, adhesion and transporter proteins that sustain cancer-cell interactions with …
Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 …
Initially, well-established breast cancer cell lines, namely SKBR3 and BT474 [9], were used to mimic the in vitro conditions representative of HER2-positive breast cancer. Optimal …
Cellosaurus cell line SK-BR-3 (CVCL_0033)
Part of: ICBP43 breast cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. From: Memorial Sloan Kettering Cancer Center; New York; USA. …
SK-BR-3: Human Breast Cancer Cell Line (ATCC HTB-30)
SK-BR-3 is a human breast cancer cell line that overexpresses the Her2 (Neu/ErbB-2) gene product. These cells display an epithelial morphology in tissue culture and are capable of …
The SKBR3 cell-membrane proteome reveals telltales of aberrant …
Jun 27, 2022 · Our work was aimed at exploring the cell-membrane proteome of a HER2+ breast-cancer cell line (SKBR3) to identify triggers responsible for uncontrolled cell proliferation and …
Mapping the cell-membrane proteome of the SKBR3/HER2+ cell …
Cell-membrane cellular subfractions of SKBR3/HER2+ breast cancer cells, used as a model system, were analyzed by high resolution mass spectrometry, and high-quality proteins …
HER2 + breast cancers evade anti-HER2 therapy via a switch in …
Nov 18, 2021 · Through genomic profiling of 733 HER2-amplified breast cancers, we identify enrichment of somatic alterations that promote MEK/ERK signaling in metastatic tumors with …
- Some results have been hidden because they may be inaccessible to you.Show inaccessible results